BridgeMD
Intraoperative Sufentanil and chronic postsurgical pain in non-major scheduled abdominal surgery
EU CTIS ID: 2023-510140-21-00
What this study is testing
to evaluate the correlation between the intraoperative administration of sufentanil doses and the incidence of CPSP at 3 months in patients undergoing non-major scheduled abdominal surgery
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age > 18 years old
- Non-major scheduled abdominal surgery.
- Written or oral informed consent to participate in the study.
You likely can't join if
- Intraoperative complications that are life-threatening or require the surgical procedure to be discontinued
- Repeat surgery at the same surgical site in less than 3 months
- Ambulatory surgery and Endoscopic surgery
- Surgery with loco-regional or perimedullary anesthesia without general anesthesia
- Intraoperative use of an opioid other than Sufentanil
- Patients suffering from psychiatric pathologies
See the full eligibility criteria
- Age > 18 years old
- Non-major scheduled abdominal surgery.
- Written or oral informed consent to participate in the study.
- Intraoperative complications that are life-threatening or require the surgical procedure to be discontinued
- Repeat surgery at the same surgical site in less than 3 months
- Ambulatory surgery and Endoscopic surgery
- Surgery with loco-regional or perimedullary anesthesia without general anesthesia
- Intraoperative use of an opioid other than Sufentanil
- Patients suffering from psychiatric pathologies
- Patients suffering from neurodegenerative pathologies
- Patients for whom self-assessment of pain using an numerical rating scale (0-10) is not feasible (language barrier, etc…)
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.